Theresa Kuntzweiler

Title: The Innovative Contributions of Theresa Kuntzweiler

Introduction

Theresa Kuntzweiler is a notable inventor based in Bernardsville, NJ (US), recognized for her significant contributions to the field of biotechnology. With a total of six patents to her name, she has made remarkable advancements in the understanding and application of prostaglandin receptor proteins.

Latest Patents

Among her latest patents is a groundbreaking invention related to nucleic acid molecules encoding prostaglandin receptor proteins. This patent describes a novel member of the prostanoid receptor family, specifically a guinea pig prostaglandin D2 receptor. The patent details the receptor, the nucleic acid that encodes it, and various potential uses for both. Another significant patent involves furosemide modulators of HM74, where host cells expressing HM74 were utilized to obtain furosemide-like molecules with agonist activity.

Career Highlights

Throughout her career, Kuntzweiler has worked with prominent companies in the pharmaceutical industry, including Aventis Pharmaceuticals Inc. and Sanofi-Aventis Deutschland GmbH. Her work in these organizations has contributed to the development of innovative therapeutic solutions.

Collaborations

Kuntzweiler has collaborated with esteemed colleagues such as Paul R. August and Mohamad Ali Ardati, further enhancing her research and development efforts in the field.

Conclusion

Theresa Kuntzweiler's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence advancements in medical science and therapeutic applications.